日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2

克唑替尼治疗MET扩增或14号外显子缺失的肿瘤患者:NCI-MATCH ECOG-ACRIN试验(EAY131)C1和C2子方案的结果

Coleman, Niamh; Wei, Zihan; Iafrate, A John; Zwiebel, James A; Sharon, Elad; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Takebe, Naoko; Williams, Travis; Croley, Jessica J; Onitilo, Adedayo A; Tricoli, James V; Cheng, Ju; Karlovich, Chris; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay; O'Dwyer, Peter J; Hong, David S; Chen, Alice P; Flaherty, Keith T

Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With BRAF(V600E) Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H

达拉非尼和曲美替尼治疗BRAF(V600E)突变肿瘤患者的II期研究:NCI-MATCH ECOG-ACRIN试验(EAY131)子方案H的最新结果

Salama, April K S; Wang, Victoria; Macrae, Erin R; Park, Jong-In; Chen, Helen X; Gray, Robert J; McShane, Lisa M; Rubinstein, Larry V; Patton, David; Williams, P Mickey; Hamilton, Stanley R; Armstrong, Deborah K; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T

Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E

拉罗替尼治疗NTRK融合肿瘤患者:NCI-MATCH ECOG-ACRIN试验(EAY131)子方案EAY131-Z1E的结果

Akhave, Neal; Song, Zihe; Hong, David S; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Takebe, Naoko; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T

Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C

帕博西尼治疗 CDK4 或 CDK6 扩增肿瘤患者的 II 期研究:NCI-MATCH ECOG-ACRIN 试验 (EAY131) 子方案 Z1C 的结果

O'Hara, Mark H; Jegede, Opeyemi; Dickson, Mark A; DeMichele, Angela M; Piekarz, Richard; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Lawrence V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Onitilo, Adedayo; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T

A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical Trial

参与NCI分子分析治疗选择临床试验的26家NGS实验室的一致性研究

Zane, Linda K; Yee, Laura M; Chang, Ting-Chia; Sklar, Jeffrey; Yang, Guangxiao; Wen, Jia Di; Li, Peining; Harrington, Robin; Sims, David J; Harper, Kneshay; Trent, Jeffrey M; LoBello, Janine R; Szelinger, Szabolcs; Benson, Kasey; Zeng, Jia; Poorman, Kelsey; Xu, Danbin; Frampton, Garrett M; Pavlick, Dean C; Miller, Vincent A; Tandon, Bevan; Swat, Wojciech; Weiss, Lawrence; Funari, Vincent Anthony; Conroy, Jeffrey M; Prescott, James L; Chandra, Pranil K; Ma, Charles; Champion, Kristen J; Baschkopf, Gregory X; Fesko, Yuri A; Freitas, Tracey Allen K; Tomlins, Scott A; Hovelson, Daniel H; White, Kevin; Sorrells, Shelly; Tell, Robert; Beaubier, Nike; King, David; Li, Lei; Kelly, Kevin; Uvalic, Jasmina; Meyers, Bridgette; Kolhe, Ravindra; Lindeman, Neal I; Baltay, Michele; Sholl, Lynette M; Lopategui, Jean; Vail, Eric; Zhang, Wenjuan; Telatar, Milhan; Afkhami, Michelle; Hsiao, Susan J; Mansukhani, Mahesh M; Adams, Emily; Jiang, LiQun; Aldape, Kenneth D; Raffeld, Mark; Xi, Liqiang; Stehr, Henning; Segal, Jeremy P; Aisner, Dara L; Davies, Kurtis D; Brown, Noah A; Livingston, Robert J; Konnick, Eric Q; Song, Wei; Solomon, James P; Walther, Zenta; McShane, Lisa M; Harris, Lyndsay N; Chen, Alice P; Tsongalis, Gregory J; Hamilton, Stanley R; Flaherty, Keith T; O'Dwyer, Peter J; Conley, Barbara A; Patton, David R; Iafrate, A John; Williams, P Mickey; Tricoli, James V; Karlovich, Chris

Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1K

伊帕他塞替治疗AKT突变肿瘤患者:NCI-MATCH ECOG-ACRIN试验(EAY131)子方案Z1K的结果

McCourt, Carolyn K; Wei, Zihan; Kalinsky, Kevin; Gray, Robert; Wang, Victoria; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Force, Jeremy; Pakanati, Anuradha; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T

Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H

Copanlisib治疗PTEN缺失患者的II期研究:NCI-MATCH ECOG-ACRIN试验(EAY131)子方案Z1G和Z1H的结果

Gouda, Mohamed A; Wei, Zihan; Rodon, Jordi; Davies, Michael A; Janku, Filip; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Liu, Raymond; Bota, Daniela A; Swiecicki, Paul L; Buchschacher, Gary L; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T

Comprehensive Molecular and Genomic Analysis of NCI-MATCH Subprotocol Y: Capivasertib in Patients With an AKT1 E17K-Mutated Tumor

NCI-MATCH Y子方案的全面分子和基因组分析:卡帕替尼治疗AKT1 E17K突变肿瘤患者

McCourt, Carolyn K; Gross, Jacob; Kalinsky, Kevin; Guan, Ping; McShane, Lisa M; Wang, Victoria; O'Dwyer, Peter J; Lahey, Matthew T; Maican, Cayden; Bu, Xiangning; Patton, David; Harris, Lyndsay N

Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J

曲妥珠单抗和帕妥珠单抗治疗非乳腺/胃食管 HER2 扩增肿瘤患者:NCI-MATCH ECOG-ACRIN 试验 (EAY131) 子方案的结果

Connolly, Roisin M; Wang, Victoria; Hyman, David M; Grivas, Petros; Mitchell, Edith P; Wright, John J; Sharon, Elad; Gray, Robert J; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Wang, Jue; Wisinski, Kari B; Tricoli, James V; Conley, Barbara A; Harris, Lyndsay N; Arteaga, Carlos L; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T

Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts

胰腺癌吉西他滨耐药性的深入研究:与代谢重编程和TP53致病性在患者来源异种移植模型中的关联

Konaté, Mariam M; Krushkal, Julia; Li, Ming-Chung; Chen, Li; Kotliarov, Yuri; Palmisano, Alida; Pauly, Rini; Xie, Qian; Williams, P Mickey; McShane, Lisa M; Zhao, Yingdong